Jump to content
  • If you are a professional or a novice we are accepting articles for submission to the next edition of the Journal of the RRDi. Click below for information on the steps you should take:

    submityourpaper.png

     

  • rrdiLogo384x64.jpg.3cd1bd79f5d066075bdd9

    We have a limited number of the Journal of RRDi available if you simply make a donation of $7 and mention you want a copy mailed to you and give us your mailing address. Otherwise, you can purchase a copy from Amazon or iUniverse.

    Paperback                  Kindle Edition

    journal_iUniverse240.png



  • journal_iUniverse.png

  • Posts

    • Arch Dermatol Res. 2021 Sep 14. doi: 10.1007/s00403-021-02277-0. Online ahead of print. ABSTRACT Botulinum toxin A (BTX-A) injections have become the most popular noninvasive cosmetic procedures performed worldwide. With growing interest, investigators continue to uncover an expanding array of aesthetic indications for BTX-A. Botulinum toxin A has been used off-label in the management of masseter hypertrophy for facial slimming, platysmal bands, nasal 'bunny' lines, perioral rhytides, gummy smile and scars, to name a few. Interestingly, the injection of multiple microdroplets of dilute BTX-A into the dermis, sometimes referred to as 'microbotox', has been investigated as a tool for facial rejuvenation. A handful of prospective studies and case series have demonstrated the benefit of BTX-A in the treatment of facial erythema and improving skin texture. The aim of this review is to summarize and appraise currently available data on the role of BTX-A in treating facial erythema and skin quality, with a special focus on potential pathophysiologic mechanisms. PMID:34519860 | DOI:10.1007/s00403-021-02277-0 {url} = URL to article
×
×
  • Create New...